Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the efficacy of ketorolac 0.4% on quality of vision
and macula thickening in patients undergoing cataract surgery using the ReStor® multifocal
IOL.